Noninvasive detection of clinically occult lymph-node metastases in prostate cancer.
By M. Harisinghani, Jelle O. Barentsz, P. Hahn, W. Deserno, S. Tabatabaei, C. H. van de Kaa, J. de la Rosette, Ralph Weissleder. New England Journal of Medicine, 2003
1,954 citations recorded by the source corpus.
Subfields: Epidemiology, Pulmonary and Respiratory Medicine
View Paper: https://www.semanticscholar.org/paper/6caf20a7b005d13ea5611624a90c421de2418615
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
In Pulmonary and Respiratory Medicine
- K. Krishnan
- J. O’Sullivan
- Isaac Koh
- John V. Frangioni
- Suneil Jain
- Hak Soo Choi
- D. Hirst
- Lee Josephson
Citations in the corpus
- Magnetic Nanoparticle Sensors (2009, positive): “CLIO is an excellent NP both for in vivo MR imaging [13] and for MRSw assay applications, because of its stability in a variety of fluids, including aqueous buffers and blood, and because of its functional handle of amino groups.”
- Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. (2014, methodology): “used in humans for the early detection of lymphatic metastases [132] and to measure increased vascular permeability in the context of inflammation [133].”
- Gold nanoparticles as novel agents for cancer therapy. (2012, background): “Targeted nanoparticles, including superparamagnetic nanoparticles and GNPs, are now being developed to improve imaging with MRI and CT [46, 47].”
- Nanomedicine for drug delivery and imaging: A promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles (2007, background): “The tumor vessel architecture is clearly visualized by MRI.”
- Biomedical Nanomagnetics: A Spin Through Possibilities in Imaging, Diagnostics, and Therapy (2010, positive): “For example, highly lymphotropic superparamagnetic nanoparticles have been used in MRI imaging to reveal [13] small nodal metastases in patients with prostate cancer not detectable by any other non-invasive methods.”
- Nanomedicine: current status and future prospects (2005, background): “nanocrystals (8) makes them ideal for such purposes.”